Mesa Laboratories, Inc. (MLAB) Stock

Technology · Scientific & Technical Instruments · Member of Other US Stocks

Mesa Laboratories, Inc. (MLAB) closed at USD 126.16 on 2026-10-14, a change of +63 % over the past year, with a market capitalization of USD 714.82M.

Mesa Laboratories, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Mesa Laboratories, Inc. key figures

Previous close

USD 126.16 (2026-10-14)

1-year change

+63 %

Market cap

USD 714.82M

Enterprise value

USD 843.93M

P/E ratio (trailing)

150.28

P/E ratio (forward)

12.44

EPS (trailing)

0.85

EPS (forward)

10.27

PEG ratio

n/a

Price to book

3.79

Revenue growth

1 %

Earnings growth

-42.4 %

Dividend per share (trailing)

0.64

Short ratio

3.41

Employees

717

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Mesa Laboratories, Inc. and compare it with other stocks.